These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 12767841)

  • 1. Effect of central venous catheter type on infections: a prospective clinical trial.
    Richards B; Chaboyer W; Bladen T; Schluter PJ
    J Hosp Infect; 2003 May; 54(1):10-7. PubMed ID: 12767841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreasing catheter colonization through the use of an antiseptic-impregnated catheter: a continuous quality improvement project.
    Collin GR
    Chest; 1999 Jun; 115(6):1632-40. PubMed ID: 10378561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of chlorhexidine/silver sulfadiazine-impregnated central venous catheters in an intensive care unit with a low blood stream infection rate after implementation of an educational program: a before-after trial.
    Schuerer DJ; Zack JE; Thomas J; Borecki IB; Sona CS; Schallom ME; Venker M; Nemeth JL; Ward MR; Verjan L; Warren DK; Fraser VJ; Mazuski JE; Boyle WA; Buchman TG; Coopersmith CM
    Surg Infect (Larchmt); 2007 Aug; 8(4):445-54. PubMed ID: 17883361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of a second-generation venous catheter impregnated with chlorhexidine and silver sulfadiazine on central catheter-related infections: a randomized, controlled trial.
    Rupp ME; Lisco SJ; Lipsett PA; Perl TM; Keating K; Civetta JM; Mermel LA; Lee D; Dellinger EP; Donahoe M; Giles D; Pfaller MA; Maki DG; Sherertz R
    Ann Intern Med; 2005 Oct; 143(8):570-80. PubMed ID: 16230723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The safety of prolonging the use of central venous catheters: a prospective analysis of the effects of using antiseptic-bonded catheters with daily site care.
    Norwood S; Wilkins HE; Vallina VL; Fernandez LG; McLarty JW
    Crit Care Med; 2000 May; 28(5):1376-82. PubMed ID: 10834681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of two antimicrobial-impregnated central venous catheters. Catheter Study Group.
    Darouiche RO; Raad II; Heard SO; Thornby JI; Wenker OC; Gabrielli A; Berg J; Khardori N; Hanna H; Hachem R; Harris RL; Mayhall G
    N Engl J Med; 1999 Jan; 340(1):1-8. PubMed ID: 9878638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of antiseptic-impregnated catheters on catheter colonization and catheter-related bloodstream infections in patients in an intensive care unit.
    Osma S; Kahveci SF; Kaya FN; Akalin H; Ozakin C; Yilmaz E; Kutlay O
    J Hosp Infect; 2006 Feb; 62(2):156-62. PubMed ID: 16307824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Oligon catheters and chlorhexidine-impregnated sponges with standard multilumen central venous catheters for prevention of associated colonization and infections in intensive care unit patients: a multicenter, randomized, controlled study.
    Arvaniti K; Lathyris D; Clouva-Molyvdas P; Haidich AB; Mouloudi E; Synnefaki E; Koulourida V; Georgopoulos D; Gerogianni N; Nakos G; Matamis D;
    Crit Care Med; 2012 Feb; 40(2):420-9. PubMed ID: 21926583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Central venous catheter colonization in critically ill patients: a prospective, randomized, controlled study comparing standard with two antiseptic-impregnated catheters.
    Dünser MW; Mayr AJ; Hinterberger G; Flörl CL; Ulmer H; Schmid S; Friesenecker B; Lorenz I; Hasibeder WR
    Anesth Analg; 2005 Dec; 101(6):1778-1784. PubMed ID: 16301258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiseptic chamber-containing hub reduces central venous catheter-related infection: a prospective, randomized study.
    León C; Alvarez-Lerma F; Ruiz-Santana S; González V; de la Torre MV; Sierra R; León M; Rodrigo JJ
    Crit Care Med; 2003 May; 31(5):1318-24. PubMed ID: 12771597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective, randomized trial of rifampicin-minocycline-coated and silver-platinum-carbon-impregnated central venous catheters.
    Fraenkel D; Rickard C; Thomas P; Faoagali J; George N; Ware R
    Crit Care Med; 2006 Mar; 34(3):668-75. PubMed ID: 16505651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream infection: a meta-analysis.
    Veenstra DL; Saint S; Saha S; Lumley T; Sullivan SD
    JAMA; 1999 Jan; 281(3):261-7. PubMed ID: 9918482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter. A randomized, controlled trial.
    Maki DG; Stolz SM; Wheeler S; Mermel LA
    Ann Intern Med; 1997 Aug; 127(4):257-66. PubMed ID: 9265424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of antiseptic-impregnated central venous catheters for prevention of catheter-related infection in intensive care unit patients.
    Sheng WH; Ko WJ; Wang JT; Chang SC; Hsueh PR; Luh KT
    Diagn Microbiol Infect Dis; 2000 Sep; 38(1):1-5. PubMed ID: 11025176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of catheter-related infections in neutropenic patients: a prospective controlled randomized trial using a chlorhexidine and silver sulfadiazine-impregnated central venous catheter.
    Jaeger K; Zenz S; Jüttner B; Ruschulte H; Kuse E; Heine J; Piepenbrock S; Ganser A; Karthaus M
    Ann Hematol; 2005 Apr; 84(4):258-62. PubMed ID: 15549302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison between the jugular and subclavian vein as insertion site for central venous catheters: microbiological aspects and risk factors for colonization and infection.
    Sadoyama G; Gontijo Filho PP
    Braz J Infect Dis; 2003 Apr; 7(2):142-8. PubMed ID: 12959686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effectiveness of chlorhexidine-silver sulfadiazine impregnated central venous catheters in patients receiving high-dose chemotherapy followed by peripheral stem cell transplantation.
    Maaskant JM; De Boer JP; Dalesio O; Holtkamp MJ; Lucas C
    Eur J Cancer Care (Engl); 2009 Sep; 18(5):477-82. PubMed ID: 19453696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of intravascular catheter-related infection with newer chlorhexidine-silver sulfadiazine-coated catheters: a randomized controlled trial.
    Brun-Buisson C; Doyon F; Sollet JP; Cochard JF; Cohen Y; Nitenberg G
    Intensive Care Med; 2004 May; 30(5):837-43. PubMed ID: 15060765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of silver-impregnated with standard multi-lumen central venous catheters in critically ill patients.
    Kalfon P; de Vaumas C; Samba D; Boulet E; Lefrant JY; Eyraud D; Lherm T; Santoli F; Naija W; Riou B
    Crit Care Med; 2007 Apr; 35(4):1032-9. PubMed ID: 17334256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of chlorhexidine and silver-sulfadiazine impregnated central venous catheters for the prevention of bloodstream infection in leukaemic patients: a randomized controlled trial.
    Logghe C; Van Ossel C; D'Hoore W; Ezzedine H; Wauters G; Haxhe JJ
    J Hosp Infect; 1997 Oct; 37(2):145-56. PubMed ID: 9364263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.